Heart Health, Inc.

Heart Health, Inc.

October 21, 2008 08:30 ET

Heart Health Inc. Pays Cash Dividends on Series B Convertible Preferred Stocks

MONTREAL, QUEBEC--(Marketwire - Oct. 21, 2008) - Heart Health, Inc. (PINK SHEETS:HHEL) is pleased to announce that the Company has paid its semiannual dividends on its Series B Convertible Preferred Stock in cash. The payments, prorated for the number of days the investment was held, were paid on October 1, 2008 and are set to be paid again on April 1, 2009, and represent an 8% annual cash return on the Series B shares. The Company has the option to pay its dividends in stock or in cash.

"The Company feels that their shares are undervalued and decided to pay a cash dividend instead of using our stock. We are excited about our current efforts to increase shareholder value. We believe the reduction in authorized shares coupled with our patent efforts should greatly enhance our share price," stated Michael Kron, Chairman and CEO of Heart Health, Inc.

Heart Health recently announced that the Company has initiated a plan to reduce the authorized shares by 75% from 2,000,000,000 to 500,000,000 in order to increase shareholder value while moving forward with its current business plan and marketing campaign.

Heart Health Inc. is in the process of finalizing the patent application it will file with the U.S. Patent and Trademark Office for the USB enabled Heart Health Monitor (HHM). The non-invasive HHM provides on-demand EKG results for patients who either require monitoring, or have a history of heart disease in the family. The device enables a trained medical professional to make a more in depth diagnosis of the user's heart condition.

About Heart Health, Inc.:

Heart Health, Inc. is focused on the development and marketing of innovative, cardiovascular medical device products. The Company intends to revolutionize the way in which people monitor the health of their hearts using newly acquired products such as the Heart Health Monitor.

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Contact Information

  • Heart Health, Inc.
    Investor Relations